Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
Mladena Glavaš, Agata Gitlin‐Domagalska, Dawid Dębowski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3068-3068
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Bioactive Peptides in Human Health and Disease
Serena Martini, Davide Tagliazucchi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5837-5837
Open Access | Times Cited: 15
Future Perspective: Harnessing the Power of Artificial Intelligence in the Generation of New Peptide Drugs
Nour Nissan, M. C. ALLEN, David A. Sabatino, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1303-1303
Open Access | Times Cited: 5
Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine
Mathieu Victor Paulin, Thomas Schermerhorn, Suraj Unniappan, et al.
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Affinity selection–mass spectrometry with linearizable macrocyclic peptide libraries
Michael A. Lee, Joseph S. Brown, Charlotte E. Farquhar, et al.
Science Advances (2025) Vol. 11, Iss. 12
Open Access
Development of Polylactic Acid Microneedles for Enhanced Transdermal Delivery of Desmopressin Peptides: A Computational Study
Ali Dashti, Milad Salimi Bani, Yegane Fanaei
Journal of Pharmaceutical Sciences (2025), pp. 103777-103777
Closed Access
Peptide Therapeutics: Current Status and Future Opportunity with Focus on Nose-to-Brain Delivery
Eva‐Maria Jülke, Annette G. Beck‐Sickinger
Peptides (2025), pp. 171404-171404
Closed Access
Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome
James W. Findling, Hershel Raff
Journal of the Endocrine Society (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 10
Vasopressin in Sepsis and Other Shock States: State of the Art
Raquel García-Álvarez, Rafael Arboleda-Salazar
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1548-1548
Open Access | Times Cited: 7
Prophylactic vasopressin to reduce intraoperative blood loss and associated morbidities during myomectomy: A systematic review and meta-analysis of 11 controlled trials
Osama Alomar, Ahmed Abu‐Zaid, Mohammed Ziad Jamjoom, et al.
Journal of Gynecology Obstetrics and Human Reproduction (2022) Vol. 51, Iss. 10, pp. 102485-102485
Closed Access | Times Cited: 11
Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
Stephen Kanes, Lara Dennie, Philip Perera
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 811-828
Open Access | Times Cited: 6
Diurnal rhythm of urinary aquaporin-2 in children with primary monosymptomatic nocturnal enuresis
Nermin Abdel Hamid Sadik, Mohamed A Abd Almawla, Aliaa Ahmed Wahby, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2024) Vol. 54, Iss. 1, pp. 194-203
Open Access | Times Cited: 2
Biopharmaceutical nanoclusters: Towards the self-delivery of protein and peptide therapeutics
M. Danielsen, Casper Hempel, Thomas L. Andresen, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 282-307
Open Access | Times Cited: 10
Nature-inspired and medicinally relevant short peptides
Maria Gessica Ciulla, Monica Civera, Sara Sattin, et al.
(2023), pp. 140-171
Open Access | Times Cited: 6
Vasopressin Use in the Support of Organ Donors: Physiological Rationale and Review of the Literature
Sofiane Ouerd, Anne Julie Frenette, David Williamson, et al.
Critical Care Explorations (2023) Vol. 5, Iss. 4, pp. e0907-e0907
Open Access | Times Cited: 5
The role of copeptin in kidney disease
Pedro Iglesias, Ramona A. Silvestre, María José Fernández‐Reyes, et al.
Endocrine (2022) Vol. 79, Iss. 3, pp. 420-429
Closed Access | Times Cited: 8
Pharmacological properties and underlying mechanisms of aurantio‑obtusin (Review)
Yao Liu, Xuemei Sun, Xinpei Hu, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 4
Pituitary disorders in patients with end-stage chronic renal failure
Т. Н. Маркова, E. V. Kosova, Н. К. Мищенко
Problems of Endocrinology (2024) Vol. 69, Iss. 6, pp. 37-46
Open Access | Times Cited: 1
One‐Pot Biocatalytic Conversion of Chemically Inert Hydrocarbons into Chiral Amino Acids through Internal Cofactor and H2O2 Recycling
Aiwen Wang, Yongze Wang, Yuanxiang You, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 48
Closed Access | Times Cited: 1
Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India
Sourav Sudan, Sahil Chaudhary, Lakshmi Deepak Bethineedi, et al.
Cureus (2023)
Open Access | Times Cited: 3
Vasopressin as a Possible Link between Sleep-Disturbances and Memory Problems
Bibiána Török, János Varga, Dóra Zelena
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15467-15467
Open Access | Times Cited: 5
OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal Hypertension
Stan Bukofzer, G. W. Harris, Susan Song, et al.
Journal of Experimental Pharmacology (2023) Vol. Volume 15, pp. 279-290
Open Access | Times Cited: 2
Chrono-communication and cardiometabolic health: The intrinsic relationship and therapeutic nutritional promises
Pamela Senesi, Anna Ferrulli, Livio Luzi, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 4
Post-Transplant Hypotension in Kidney Recipients—Vasopressin to the Rescue?
Divya Bajpai, Thangamani Muthukumar
Kidney International Reports (2022) Vol. 7, Iss. 6, pp. 1161-1164
Open Access | Times Cited: 3
Therapeutic potential of vasopressin in the treatment of neurological disorders
Shweta Mishra, Jyoti Grewal, Pranay Wal, et al.
Peptides (2024) Vol. 174, pp. 171166-171166
Closed Access
Page 1 - Next Page

Scroll to top